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Abstract
Neonatal Borna Disease Virus (BDV) infection in rats leads to a neuronal loss in the cortex,
hippocampus and cerebellum. Since BDV is a non-lytic infection in vitro, it has been suggested that
activated microglia could contribute to neuronal damage. It is also conceivable that BDV-induced
cell death triggers activation of microglia to remove cell debris. Although an overall temporal
association between neuronal loss and microgliosis has been demonstrated in BDV-infected rats,
it remains unclear if microgliosis precedes or results from neuronal damage. We investigated the
timing of microglia activation and neuronal elimination in the dentate gyrus (DG) of the
hippocampus. We found a significant increase in the number of ED1+ microglia cells as early as 10
days post infection (dpi) while a detectable loss of granule cells of the DG was not seen until 30
dpi. The data demonstrate for the first time that a non-lytic persistent virus infection of neurons
activates microglia long before any measurable neuronal loss.
Findings
Activation of microglia is a hallmark of many neurode-
generative conditions produced by genetic mutations or
environmental factors, including viral infections [1,2].
However, whether microglia activation is a cause or con-
sequence of neuronal loss often remains unclear. Neona-
tal Borna Disease Virus (BDV) infection in rats is an
example of neurodegenerative behavioral disease that is
associated with activation of microglia and astrocytes and
loss of neurons in the DG of the hippocampus, cortex,
and cerebellum [3-6]. While an overall temporal associa-
tion of neuronal death with microgliosis has been shown
in neonatally BDV-infected rats, the precise timing of
microglia activation has not been studied, and it remains
unknown if microglia activation precedes neuronal loss or
results from it [7-9]. This question is of importance since
BDV is a non-lytic neurotropic virus and does not kill neu-
rons in vitro, suggesting that activation of microglia may
trigger neuronal damage and/or exacerbate initial subtle
dysfunctions produced by the virus. In this regard, BDV
infection pathogenesis may resemble some other chronic
neurodegenerative conditions where initial neuronal dis-
turbances lead to activation of microglia and ensuing neu-
rodegeneration [1,2]. Thus, we quantitatively evaluated
the timing of microglia activation and neuronal injury at
early time points post infection.
Pregnant Fischer344 rats at 16–18 days of gestation were
purchased for the present study (Harlan, Indianapolis,
IN). All rat pups were born in the animal facility at Johns
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Hopkins University School of Medicine, Baltimore, MD.
Mothers and their litters were housed in 45 × 26 × 23 cm
pan-type polypropylene cages with paper-chip bedding
and an overhead wire grid supporting food pellets and a
water bottle. The cages containing BDV and sham-infected
animals were kept in a DUO-FLO biosafety cabinet (Bio-
Clean Lab Product Inc., NJ). Rats of all the groups were
maintained on a 12/12-hr light/dark cycle (lights on at 8
a.m.). Room temperature was maintained at approxi-
mately 21°C. The pregnant and nursing rats had free
access to food and water. After weaning, on postnatal day
23, the rats continued to have free access to food and
water. Rat pups were inoculated intracranially under
hypothermia anesthesia with 26-G needles within 24
hours of birth either with 20μL of infectious inoculum
containing 104 TICD50 of He-80 BDV strain or uninfected
inoculum as described previously [3,10]. All experiments
were performed with adherence to the National Institutes
of Health guidelines on the use of experimental animals
and the animal protocol approved by the Johns Hopkins
Medical Institutions' Animal Care and Use Committee.
To investigate a precise temporal relationship between
microglia activation and neurodegeneration, infected and
uninfected rat pups were sacrificed at 8, 10, 17, and 30
days post infection (dpi) with EUTHASOL (Diamond Ani-
mal Health, Inc. IA) and immediately perfused with ice-
cold phosphate buffered saline (PBS, pH = 7.4) followed
by 4% paraformaldehyde. Brains were removed, postfixed
for 4 hours, cryoprotected in 30% sucrose in PBS, cut sag-
ittally in half and frozen on dry ice. The right and left
halves were cut saggitally in 40-μm sections for either
immunofluorescence or immunohistochemical staining
using standard protocols. Brains sections were co-stained
with rabbit anti-GFAP (1:800, Chemicon, Temecula, CA)
as a marker for astrocytes; anti-ED1 MAB (1:100, Chemi-
con), anti-CD11b MAB (1:100, R&D), anti-Iba1 (1:800)
as the markers for microglia, and anti-BDV N Mo18 MAB
(1:100, a generous gift by Dr Juergen Richt, National Ani-
mal Disease Center, 2300 Dayton Avenue, Ames, IA) [11]
antibodies followed by either FITC-conjugated or Cy3-
conjugated secondary antibodies (1:200, Chemicon) or
biotinylated anti-mouse (for anti-BDV) or anti-rabbit (for
anti-GFAP) antibodies followed by DAB (a brown reac-
tion product) or Vector® VIP substrate (a purple reaction
product) chemical visualization, respectively (Vector Lab,
Burlingame, CA). Antibodies against ED1, CD11b and
Iba1 were used to detect microglia [7,9]. Although mono-
cytes, B and T cells, and macrophages can also express
these markers, we refer to the labeled cells as microglia
because mononuclear infiltration of the brain paren-
chyma during neonatal BDV infection in rats is minimal
and transient [9]. In addition, a double staining with anti
CD3 antibody was used to stain macrophages that were
found only in the meninges. Those round macrophages
were double positive for CD3 and ED1 but were morpho-
logically different from stellar-shaped microglia in the
hippocampal area (data not shown).
Our pilot experiments had shown that CD11b+ and Iba1+
cells were found in both BDV-infected rats and control
animals, indicating that those markers were likely to label
both activated and inactivated microglia in rats (data not
shown). In contrast, ED1+ microglia were observed pre-
dominantly in BDV-infected brains (Fig. 1A and 1B), sug-
gesting that ED1 could be used as a reliable marker for
BDV-activated microglia. In order to rule out the effects of
inoculation-associated tissue damage on ED+ staining, we
had also performed a preliminary comparison of numbers
of ED1+ cells in the left (the place of inoculation) and the
right (intact) hemispheres and showed no differences
between hemispheres at 8, 10 and 17 dpi (data not
shown). In addition, compared to intracerebral inocula-
tion, intranasal instillation with the virus produced a sim-
ilar increase in ED+ cells in the hippocampus (data not
shown). Collectively, our preliminary experiments had
indicated that ED1 is a specific marker of BDV-induced
microglia activation. Thus, ED1-positive staining was
used in the study to quantitatively evaluate microglia acti-
vation in BDV-infected rats.
Images of brain sections were viewed on fluorescent
microscope Nikon Eclipse E400 equipped with the digital
camera CoolSnap™ ES (Roper Scientific Production). Esti-
mation of the numbers of ED1+ microglia was performed
by counting ED-labeled cells, using microscopic fields
sampled in the equidistant parts of the DG in the right
(intact from intracranial inoculation) hemisphere as pre-
sented on Figure 1B. The average number of ED1+ cells for
three adjacent brain sections at the same levels was deter-
mined for each rat. Then, the averaged number of ED1+
microglia cells in the DG was determined for each group,
with the number of animals per each group being n = 3 (8
dpi); 8 (10 dpi); 5 (17 dpi); 4 (30 dpi). The data are pre-
sented as the mean (for each group) ± S.E.M.
For an analysis of neuronal loss in the DG, a stereology-
based approach was employed as described before [10].
Briefly, the brains used for ED1 staining were used for the
stereology counts as well. Every fifth brain section of one
hemisphere from each rat was separately collected in PBS
in 12-well plates and stained with cresyl violet. The
dimensions of the optical dissector for DG neurons were:
height 12.00 μm; guard height 2 μm, spacing 1250 μm.
The co-efficient of error (CE) was below 10% for all ani-
mals. To count neurons, an image of counting regions was
displayed on the video monitor and a square counting
box superimposed on the image using the stereology soft-
ware Stereologer (SPA Alexandria, VA, USA). Sections
were viewed with a 100× objective (final magnification onJournal of Neuroinflammation 2008, 5:16 http://www.jneuroinflammation.com/content/5/1/16
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the computer screen: 2200×). The brain hemispheres used
for counting neurons were also used for measuring the
volumes of the DG, using Cavalieri point counting [10].
The data was analyzed with Student t-test for each time
point separately. P value below 0.05 was used as the indi-
cation of significant differences.
We found a significant increase in the number of activated
microglia cells as early as 10 dpi (Fig. 1B and 1D). The
number of ED1+ cells in the brain remained significantly
higher in BDV-infected rats until 30 dpi (Fig. 1D). BDV-
infected neurons were predominantly found in the areas
with the high density of ED1+ cells (Fig 1C). BDV infec-
tion during the first three weeks post inoculation was
found to be limited to neurons only, with occasional
staining of astrocytes being found at 30 dpi (data not
shown). Despite this rise in the number of activated
microglia cells across the first three weeks after inocula-
tion with the virus, the numbers of granule cells and the
volumes of the DG continued to increase at a comparable
rate with mock-infected rats until 17 dpi. (Fig. 1E and 1F).
It is at the last time point only (i.e., 30 dpi), when a signif-
icant decrease in the number of granule cells and the vol-
umes of DG was found in BDV-infected rats compared to
control animals (Fig. 1E and 1F). We also evaluated acti-
vation of microglia in the CA3 and CA1 areas of the hip-
pocampus where minimal if any neuronal damage was
reported [10]. At 10 dpi, BDV infection was associated
with significantly more CD1-positive cells: BDV – 25.3 ±
6.4 vs. Mock – 0.7 ± 0.3 in the CA1 area; and BDV – 12.7
± 5.1 vs. Mock – 1.7 ± 0.5 in the CA3 area (n = 4 for each
group, t-test, p < 0.05).
Activation of microglia by BDV infection prior to neuronal loss in the hippocampus Figure 1
Activation of microglia by BDV infection prior to neuronal loss in the hippocampus. (A) No ED1+ cells in the sec-
tion from a mock-infected rat, 10 dpi. Scale bar – 35 um; dg – the dentate gyrus; h – the hilus area. (B) BDV infection produces a 
significant increase in the number of ED1+ cells in the dentate gyrus. The white squares depict the areas where ED+ cells were 
counted; dg – the dentate gyrus; h – the hilus area; arrows point to ED1+ activated microglia cells; 10 dpi. (C) BDV-infection in 
neurons of the hippocampus. Double-immunostaining of the brain section from a BDV-infected rat at 10 dpi. Note BDV-positive 
(brown) staining in neurons (arrows) and GFAP-positive (purple) staining in astrocytes (arrowheads). Scale bar – 25 μm; dg – the 
dentate gyrus. (D) The quantitative analysis of ED1+ cells in the dentate gyrus of the hippocampus in mock-(open bars) and 
BDV-infected (solid bars) rats. Note a significant increase in the number of activated microglia cells as early as 10 dpi. * – p < 
0.05 vs. mock-infected animals. (E) The quantitative estimate of the number of granule cells in the dentate gyrus of the hippoc-
ampus in mock-(open bars) and BDV-infected (solid bars) rats. Note that a significant decline in the number of granule cells was 
not observed until 30 dpi. * – p < 0.05 vs. mock-infected animals. (F) The quantitative estimate of the volume of the dentate 
gyrus of the hippocampus in mock-(open bars) and BDV-infected (solid bars) rats. Note that a significant decrease in the volume 
of the dentate gyrus of the hippocampus was not seen until 30 dpi. * – p < 0.05 vs. mock-infected animals.
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We demonstrated for the first time that neonatal BDV
infection activates microglia at least two weeks prior to an
appreciable neuronal loss in the DG of the hippocampus,
the brain region that undergoes most profound and accel-
erated neurodegenerative changes [3,7,8]. This data is fur-
ther supported by the results on a significant activation of
microglia in the CA areas of the hippocampus that has
been shown to harbor highest amounts of BDV in the
absence of detectable signs of neuronal injury [4,10]. The
findings show that activation of microglia is an early
response to neonatal BDV infection in rats, suggesting that
microgliosis could trigger demise of infected neurons or
exacerbate on-going subtle dysfunction initiated by the
direct virus infection [12-14]. BDV-produced neurodegen-
eration and perhaps slower adult neurogenesis [15] in the
DG will also likely affect the overall composition, average
age and identity of DG cells, and will probably have con-
siderable consequences for the connectivity, input and
properties of the hippocampal DG-CA3 neuronal circuit,
resulting in emotional and cognitive abnormalities
observed in BDV-infected rats [5,7].
The present data are consistent with our previous in vitro
studies that BDV infection of primary neuronal and astro-
cyte cultures does not induce neuronal toxicity for weeks
post infection but increases the number of activated
microglia cells in mixed neuronal-astroglia-microglia cul-
tures [16]. The mechanisms whereby persistent non-lytic
BDV infection activates microglia remain obscure. Our
previous report has demonstrated BDV does not infect
microglia in vitro and BDV-infected neurons do not acti-
vate microglia. It is in BDV-infected mixed cultures con-
taining neurons, astrocytes and microglia that we see
activation of microglia in the absence overt neuronal tox-
icity, suggesting that microglia activation appears a result
of complex interactions between BDV-infected neurons,
astrocytes and microglia. In a broader context, activation
of microglia by neonatal BDV infection resembles several
neurodegenerative conditions where microglia may ini-
tially respond to subtle abnormalities well before overt
neuronal damage is produced [2,17].
Taken together, the present findings provide for the first
time direct evidence that neonatal BDV infection pro-
duces microglia activation prior neuronal death and sug-
gest that chronic neuroinflammation may contribute to
neuronal damage associated with a persistent neurotropic
virus infection.
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